HealthKart weighs $300–400 million IPO as nutrition retail scales

The MuscleBlaze, HK Vitals and Gritzo operator is considering a public issue comprising primary capital and secondary share sales. HealthKart reported FY25 operating income of ₹1,312.61 crore and profit of ₹119.98 crore, while its offline network exceeds 200 stores across 90-plus cities.

— Source publishedFri, 18 Sept, 2026, 10:37 IST·First seen Fri, 18 Sept, 2026, 10:45 IST·Source Mint

What happened

Indian nutrition platform HealthKart is weighing a $300-400 million IPO, combining primary capital and secondary share sales. The MuscleBlaze, HK Vitals and

Key facts

  • $300-400 million proposed IPO raise
  • ₹2,800-3,800 crore proposed IPO raise
  • Over 200 offline stores across more than 90 cities
  • $153 million secondary funding round in 2024
  • ₹55 crore employee stock-option buyback
  • About $500 million valuation
  • FY25 operating income ₹1,312.61 crore
  • FY25 profit ₹119.98 crore

Why this matters

Potential public-market funding raises the competitive stakes for nutrition, wellness and specialty retail players, making brand acquisitions, distribution partnerships and offline expansion more strategic.

What to watch

  • Formal banker mandates, registrar/legal advisor appointments and any filing timeline for draft IPO documents.
  • Primary-versus-secondary issue mix, use of proceeds and whether major shareholders materially reduce stakes.
  • FY26 revenue growth, EBITDA/profit conversion, cash generation and working-capital movement relative to FY25 operating income of ₹1,312.61 crore and profit of ₹119.98 crore.
  • Same-store sales, store payback periods, total outlet count and contribution of offline channels versus app, website and marketplace sales.
  • Repeat-order rates, share of owned brands, gross-margin trajectory and customer-acquisition-cost trends.
  • FSSAI actions, product-quality incidents, influencer-marketing restrictions or tightening of health-claim rules affecting supplements.
  • IPO performance and valuations of Indian consumer, beauty, pharmacy, wellness and D2C listings over the next 12 months.
  • Appoint IPO bankers, begin diligence and sharpen disclosures around revenue mix, gross margin, repeat purchases, cohort retention and offline-store economics.
  • Increase emphasis on profitable owned brands including MuscleBlaze, HK Vitals and Gritzo to support margin expansion and differentiation from marketplace-led supplement sellers.
  • Rationalize offline expansion toward high-productivity cities, franchise-like capital-light formats or shop-in-shop partnerships to demonstrate scalable store returns.
  • Build regulatory, quality-control and anti-counterfeit messaging as public-market investors scrutinize supplement safety, claims substantiation and marketplace leakage.
  • Potentially use pre-IPO financing to strengthen working capital, warehousing, manufacturing/vendor relationships and selective acquisitions in women’s health, sports nutrition or pediatric wellness.